HOTH News and Press, Hoth Therapeutics Inc. From 01/13/21

Acorda Therapeutics (ACOR) +54% after announcing agreement for sale of manufacturing operations and long-term global supply agreement.Summit Midstream Partners (SMLP) +45% after winning FERC construction OK.WiMi Hologram Cloud (WIMI) +38% on obtaining a patent for a 3D holograp...

Hoth Therapeutics' (HOTH) jumps 15% premarket in reaction to the announcement that its Pre-IND meeting requested on Dec. 22 for HT-001 with the FDA has been granted to receive written responses that are targeted for delivery on February 22, 2021. The Pre-IND meeting topics incl...

FDA Grants Hoth Therapeutics Pre-IND Meeting Regarding Proposed Drug Development Plan for HT-001 Treatment for Cancer Patients PR Newswire NEW YORK , Jan. 13, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today ann...

Hoth Therapeutics (HOTH) announces an agreement with Charles River Laboratories (CRL) to initiate preclinical studies of HT-001, a topical formulation designed for the treatment of rash and skin disorders associated with initial and repeat EGFR inhibitor cancer treatment.Together with Ch...

Hoth Therapeutics to Initiate IND Enabling Studies of HT-001 Treatment for Cancer Patients PR Newswire NEW YORK , Jan. 11, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced an agreement with Charles River ...

Hoth Therapeutics (HOTH) has entered into a definitive securities purchase agreement in connection with a private placement to institutional investors.The Company expects to receive gross proceeds of ~$5M, not including any proceeds from exercise of warrants. Under the agreement, th...

Hoth Therapeutics Announces Private Placement of Equity Priced At-The-Market Under Nasdaq Rules Definitive Agreement for $5.0 Million in Gross Proceeds PR Newswire NEW YORK , Jan. 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharm...

Bionano Genomics (BNGO) -22%.Stable Road Acquisition (SRAC) -12% Momentus updates on 2021 mission, merger with SRAC remains on track to close in Q1.ViewRay (VRAY) -12% after prices equity offering at $4.85.AirNet Technology (ANTE) -11%.TransEnterix (TRXC) -13%.Hall of...

Hoth Therapeutics (HOTH) jumps 15% premarket in reaction to the announcement that its has entered into a Non-Exclusive Commercial Evaluation License Agreement with the U.S. Army Medical Research and Development Command for a new molecular entity ((NME)) developed by the Walter ...

Hoth Therapeutics Announces Licensing Agreement and Collaboration with U.S. Army Medical Research and Development Command (USAMRDC) for Treating Multi-Drug Resistant Bacterial Lung Infections License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Re...